BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17873130)

  • 21. A revisit to quantitative PET with
    Akamatsu G; Ohnishi A; Aita K; Nishida H; Ikari Y; Sasaki M; Kohara N; Senda M
    Ann Nucl Med; 2017 Feb; 31(2):163-171. PubMed ID: 27914043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IDH mutation is paradoxically associated with higher
    Verger A; Metellus P; Sala Q; Colin C; Bialecki E; Taieb D; Chinot O; Figarella-Branger D; Guedj E
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1306-1311. PubMed ID: 28293705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
    Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
    J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
    Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
    J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Patel CB; Fazzari E; Chakhoyan A; Yao J; Raymond C; Nguyen H; Manoukian J; Nguyen N; Pope W; Cloughesy TF; Nghiemphu PL; Czernin J; Lai A; Ellingson BM
    J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
    Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
    J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
    Moreau A; Giraudet AL; Kryza D; Borson-Chazot F; Bournaud C; Mognetti T; Lifante JC; Combemale P; Giammarile F; Houzard C
    Nucl Med Commun; 2017 Sep; 38(9):771-779. PubMed ID: 28704339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simulation-based partial volume correction for dopaminergic PET imaging: Impact of segmentation accuracy.
    Rong Y; Vernaleken I; Winz OH; Goedicke A; Mottaghy FM; Kops ER
    Z Med Phys; 2015 Sep; 25(3):230-42. PubMed ID: 25172832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.
    Dimitrakopoulou-Strauss A; Strauss LG; Burger C
    J Nucl Med; 2001 Feb; 42(2):248-56. PubMed ID: 11216523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
    Muzi M; Spence AM; O'Sullivan F; Mankoff DA; Wells JM; Grierson JR; Link JM; Krohn KA
    J Nucl Med; 2006 Oct; 47(10):1612-21. PubMed ID: 17015896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.
    Kumakura Y; Cumming P
    Neuroscientist; 2009 Dec; 15(6):635-50. PubMed ID: 19793723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
    Jokinen P; Helenius H; Rauhala E; Brück A; Eskola O; Rinne JO
    J Nucl Med; 2009 Jun; 50(6):893-9. PubMed ID: 19443601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting ¹⁸F FDOPA standardized uptake value in patients with primary brain tumors after treatment.
    Chiaravalloti A; Fiorentini A; Villani V; Carapella C; Pace A; Di Pietro B; Di Russo C; Palumbo B; Floris R; Schillaci O
    Nucl Med Biol; 2015 Apr; 42(4):355-9. PubMed ID: 25624151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
    Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
    J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
    Brust P; Vorwieger G; Walter B; Füchtner F; Stark H; Kuwabara H; Herzau M; Opfermann T; Steinbach J; Ganapathy V; Bauer R
    Brain Res Dev Brain Res; 2004 Sep; 152(2):241-53. PubMed ID: 15351512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling of fluorine-18-6-fluoro-L-Dopa in humans.
    Wahl L; Nahmias C
    J Nucl Med; 1996 Mar; 37(3):432-7. PubMed ID: 8772639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.
    Dadone-Montaudié B; Ambrosetti D; Dufour M; Darcourt J; Almairac F; Coyne J; Virolle T; Humbert O; Burel-Vandenbos F
    PLoS One; 2017; 12(9):e0184625. PubMed ID: 28937983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rate of change in maximum
    Oughourlian TC; Yao J; Schlossman J; Raymond C; Ji M; Tatekawa H; Salamon N; Pope WB; Czernin J; Nghiemphu PL; Lai A; Cloughesy TF; Ellingson BM
    J Neurooncol; 2020 Mar; 147(1):135-145. PubMed ID: 31981013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [¹⁸F]FDOPA PET by a model with detailed dopamine pathway.
    Matsubara K; Watabe H; Kumakura Y; Hayashi T; Endres CJ; Minato K; Iida H
    Synapse; 2011 Aug; 65(8):751-62. PubMed ID: 21190220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.